Viewing Study NCT03934567


Ignite Creation Date: 2025-12-25 @ 12:40 AM
Ignite Modification Date: 2026-02-22 @ 11:47 PM
Study NCT ID: NCT03934567
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-10
First Post: 2019-04-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma
Sponsor: Xynomic Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module